Unknown

Dataset Information

0

Transient structural distortion of metal-free Cu/Zn superoxide dismutase triggers aberrant oligomerization.


ABSTRACT: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease linked to the misfolding of Cu/Zn superoxide dismutase (SOD1). ALS-related defects in SOD1 result in a gain of toxic function that coincides with aberrant oligomerization. The structural events triggering oligomerization have remained enigmatic, however, as is the case in other protein-misfolding diseases. Here, we target the critical conformational change that defines the earliest step toward aggregation. Using nuclear spin relaxation dispersion experiments, we identified a short-lived (0.4 ms) and weakly populated (0.7%) conformation of metal-depleted SOD1 that triggers aberrant oligomerization. This excited state emanates from the folded ground state and is suppressed by metal binding, but is present in both the disulfide-oxidized and disulfide-reduced forms of the protein. Our results pinpoint a perturbed region of the excited-state structure that forms intermolecular contacts in the earliest nonnative dimer/oligomer. The conformational transition that triggers oligomerization is a common feature of WT SOD1 and ALS-associated mutants that have widely different physicochemical properties. But compared with WT SOD1, the mutants have enhanced structural distortions in their excited states, and in some cases slightly higher excited-state populations and lower kinetic barriers, implying increased susceptibility to oligomerization. Our results provide a unified picture that highlights both (i) a common denominator among different SOD1 variants that may explain why diverse mutations cause the same disease, and (ii) a structural basis that may aid in understanding how different mutations affect disease propensity and progression.

SUBMITTER: Teilum K 

PROVIDER: S-EPMC2775296 | BioStudies | 2009-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5216565 | BioStudies
2018-01-01 | S-EPMC5856554 | BioStudies
2017-01-01 | S-EPMC5326558 | BioStudies
1000-01-01 | S-EPMC2900889 | BioStudies
1000-01-01 | S-EPMC2757158 | BioStudies
2009-01-01 | S-EPMC2850267 | BioStudies
2009-01-01 | S-EPMC2749781 | BioStudies
2014-01-01 | S-EPMC4175315 | BioStudies
2011-01-01 | S-EPMC3182705 | BioStudies
2020-01-01 | S-EPMC7458393 | BioStudies